Objective: The purpose of this study was to examine the role of the genital mycoplasmas Mycoplasma hominis and Ureaplasma urealyticum as causes of bacteremia in a tertiary referral obstetrical, gynecological, and neonatal intensive care facility, over a period of 12 years from 1983 to 1994 inclusively.
found as part of the endogenous microflora of the vagina of sexually active women, with colonization rates of 20% and 40-70%, respectively. 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 Average   Total population  No. of isolates   60  41  47  40  35  49  58  91  109  91  84  121  69 Positivity ratemU, urealyticum (%) In particular, blood culture media containing sodium polyanetholesulfonate (SPS) inhibit the growth of both of these bacteria, s
We From 1983 to 1986, the routine blood culture media used were an anaerobic Schaedler broth and an aerobic biphasic tryptone soya agar with 50 ml of tryptone soya broth medium, free of SPS, as previously described. 4 Media were incubated at 37C for 7 days and inspected daily. Subculture of observed growth, as well as blind subculture at 48 h were performed as previously described, including culture for conventional aerobic and anaerobic bacteria and also for genital mycoplasmas using ureaplasma differential agar (modified A7) from the SPS-free aerobic medium. 4 Subsequently, in 1987, a change was made to the Bactec blood culture system (Becton, Dickinson & Co., Cockeysville, MD). The media used for adults were 6B (aerobic enriched tryptic soya broth) and 7DX (anaerobic enriched tryptic soya broth without SPS). For infants the media used were PedsPlus (enriched tryptic soya broth with antimicrobial removing resins) and 7DX. All Bactec media were incubated for 7 days at 37C. The growth index was measured using the Bactec reader 460. Blind subculture was made from the SPS-free 7DX medium routinely after 48 h onto a modified A7 agar and incubated anaerobically for 2 days. Identification ofM. hominis and U. urealyticum was as previously described. 4 11, 3, 14 In conclusion, we believe that in a tertiary care obstetric, gynecological, and neonatal intensive care facility it is worthwhile and appropriate that the servicing microbiology laboratory specifically examine blood culture for the genital mycoplasmas in clinical settings where mycoplasmaemia is suspected.
